Should I Buy CAMT? CAMT 2026 Analysis

Should You Buy Camtek Ltd (CAMT) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Buy

Latest Price

149.020

1 Day change

5.61%

52 Week Range

155.790

Analysis Updated At

2026/02/05

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Buy now (tactical): price is rebounding pre-market (+4.28% to 138.43) from a key support zone (~132.8), suggesting a near-term bounce setup.
Trend still constructive on a multi-timeframe basis (SMA_5 > SMA_20 > SMA_200), even though momentum (MACD) has been weak recently.
Street sentiment is improving (multiple price-target raises in Jan) and the AI/HBM advanced-packaging demand narrative remains a strong tailwind.
Main near-term risk is event-driven with earnings imminent (2026-02-11 pre-market per calendar), which can create sharp moves; options are pricing elevated volatility.

Technical Analysis

Pre-market tape: 138.43 (+4.28%) implies a bounce attempt after trading near S1 support ~132.81 (options snapshot spot 132.75).
Trend/MAs: Bullish structure with SMA_5 > SMA_20 > SMA_200 (uptrend / buy-the-dip regime).
Momentum: MACD histogram -1.869 and negatively expanding = downside momentum has been dominant recently (trend is bullish, but momentum needs to re-confirm).
RSI (6): 29.6 = near-oversold/washed-out short-term condition, consistent with bounce potential.
Levels: Support S1 132.81, then S2 126.47. Resistance/pivot 143.08, then R1 153.34.
Pattern stats (similar candlesticks): Model suggests ~60% chance of gains with indicative moves of +3.37% (1D), +4.72% (1W), +5.4% (1M).

Options Data

Neutral

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Positioning (OI PCR 0.97): essentially neutral (no strong skew toward puts or calls).
Flow (Volume PCR 0.72): more calls than puts in volume terms = mildly bullish near-term sentiment.
Volatility pricing: 30D IV 74.61 vs HV 58.66 and IV percentile 92.83 = options are pricing elevated event risk (consistent with upcoming earnings window).
Activity: Today’s volume 134 vs 5D avg 314 / 10D avg 235.4 = below recent average, so sentiment signal is mild rather than decisive.

Technical Summary

Sell

Buy

Positive Catalysts

- Earnings catalyst: QDEC 2025 earnings scheduled 2026-02-11 pre-market (calendar), which can re-rate the stock if guidance/AI packaging demand is strong.
- AI/HBM/advanced packaging exposure repeatedly highlighted by analysts as a durable demand driver (HBM, CoWoS, GPUs, ASICs; OSAT/memory tool demand).
- Pre-market strength today (+4.28%) indicates buyers stepping in near support.
- Gross margin improvement (Q3 2025 GM 50.43%, +1.43% YoY) supports quality of revenue and product mix narrative.

Neutral/Negative Catalysts

- Momentum weakness: MACD still bearish/expanding downside momentum despite bullish moving averages.
- Event risk: options imply elevated volatility into the earnings window; sharp downside is possible if guidance disappoints.
- Q3 profitability shock: latest provided quarter shows net income and EPS turning sharply negative (likely non-recurring, but still a sentiment overhang until clarified).
- No supportive “smart money” signal: hedge fund and insider activity described as neutral; no notable accumulation signal from those datasets.

Financial Performance

Latest quarter provided: 2025/Q3
Revenue: 125.993M, +12.15% YoY (solid top-line growth).
Gross margin: 50.43%, +1.43% YoY (margin trend positive).
Net income: -53.181M, -262.42% YoY; EPS -1.16 (-275.76% YoY) (major profitability deterioration vs prior year; likely one-time/exceptional items or cost step-up—needs confirmation in the next report).
Overall read: growth and margins look healthy, but the reported earnings drawdown is the key financial “red flag” until management explains normalization.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Trend: clear upward drift in price targets through Jan 2026.
Recent upgrades/raises:
- B. Riley (2026-01-26) Buy, PT 175 (from 145)
- Needham (2026-01-20) Buy, PT 160 (from 135)
- Goldman (2026-01-09) Neutral, PT 141 (from 123)
- Multiple other firms raised PTs into the 120–140 range (BofA Buy 140; Jefferies Buy 140; Evercore Outperform 130, etc.)
Wall Street pros: strong structural demand narrative (AI, HBM, advanced packaging/process control), product cycle (new tools), share-gain potential.
Wall Street cons: near-term cyclicality/capacity absorption timing and a more “balanced” risk/reward view from Neutral-rated shops at elevated prices.

12 Analyst Rating

Wall Street analysts forecast CAMT stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for CAMT is 129.08 USD with a low forecast of 110 USD and a high forecast of 145 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

9 Buy

3 Hold

0 Sell

Strong Buy

Current: 141.110

Low

110

Averages

129.08

High

145

Current: 141.110

Low

110

Averages

129.08

High

145

B. Riley

Buy

upgrade

$145 -> $175

AI Analysis

2026-01-26

Reason

B. Riley

Price Target

$145 -> $175

AI Analysis

2026-01-26

upgrade

Buy

Reason

B. Riley raised the firm's price target on Camtek to $175 from $145 and keeps a Buy rating on the shares. Despite near-term cyclical pressure, structurally strong AI-driven demand for HBM, CoWoS, GPUs, and custom ASICs continues to outstrip supply, the analyst tells investors in a research note. Quarterly execution is expected to come in slightly above consensus, driven by sustained strength in HPC advanced packaging and solid order and shipment conversion for new Eagle G5 and Hawk tools at memory and OSAT customers, the firm says.

Needham

NULL -> Buy

upgrade

$135 -> $160

2026-01-20

Reason

Needham

Price Target

$135 -> $160

2026-01-20

upgrade

NULL -> Buy

Reason

Needham raised the firm's price target on Camtek to $160 from $135 and keeps a Buy rating on the shares. Commentary from the Needham Growth Conference pointed to broad-based demand improvement over the past 90 days, supporting a bullish sector outlook, the analyst tells investors in a research note. Despite strong year-to-date performance, the direction for semicap remains positive, with Q4 earnings expected to deliver multiple catalysts, the firm says.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for CAMT

Unlock Now

CAMT Should I Buy

CAMT Should I Buy

Should You Buy Camtek Ltd (CAMT) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch